Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30 2024 & other business with the permission of Chair.